NEKTAR THERAPEUTICS
Industry: Life Sciences ・ $NKTR on Nasdaq
Insider Sale
+$10,403
-3.15%
Shares
Shares Volume: 10,300 Shares
Average Share Price: $1.01
INSIDER
Zalevsky Jonathan
Chief R&D Officer (Officer)
reported on Feb 21 2025
traded on Feb 19 2025
TRADE ACTIVITY 1Y
current insider trade in blue
INSIDER ACTIVITY
| NEW SHARES OWNERSHIP AMOUNT | 316,604 |
| PURCHASES/SALES 1Y | 0 / 6 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $15,683.87 |
| INSIDER PREVIOUS TRADES |
COMPANY OVERALL ACTIVITY
INSIDERS IN PAST 2 WEEKS with at least one purchase / sale | 0 / 3 |
| PURCHASES/SALES 1Y | 0 / 20 |
| P/S VALUE RATIO | N/A |
| AVERAGE SALE VALUE | $26,871.05 |
| COMPANY PREVIOUS TRADES |